Fiserv jumps on report of talks to sell payments infrastructure unit; Vertex to buy Crinetics for $10 billion

According to CNBC, Fiserv shares rallied more than 5% after Reuters, citing a source familiar with the matter, reported the fintech company has talked with major U.S. banks including JPMorgan and Bank of America to sell its payments infrastructure business that handles debit card transactions. Vertex Pharmaceuticals and Crinetics Pharmaceuticals said Monday that Vertex will buy Crinetics in a $10 billion deal to acquire treatments for rare hormonal diseases; Vertex shares dipped nearly 1% while Crinetics shares roughly doubled. First Solar rose nearly 3% after Deutsche Bank upgraded the stock to buy from neutral. Chip stocks slid in premarket trading after mixed quarterly results from Samsung overnight, with Micron and Lam Research down 5% each.